Global /Germany /Healthcare /Biotechnology /BIG1

Bio-Gate AG

BIG1

• XETRA: BIG1 • Delayed

0.6600EUR 3.9%

0.7666 USD

As of 5 June 2026, Bio-Gate AG has a market cap of $6.63M USD, ranking #43327 globally and #417 in Germany. It ranks #3838 in the Healthcare sector, and #755 in the Biotechnology industry.

Global Rank

43327

Country Rank

417

Sector Rank

3838

Industry Rank

755

Key Stats

Market Cap

$6.63MUSD

5.71M EUR

Enterprise Value

$6.94MUSD

5.97M EUR

Revenue (TTM)

$8.12MUSD

6.99M EUR

EBITDA (TTM)

-$1.24MUSD

-1.07M EUR

Net Income (TTM)

-$1.6MUSD

-1.38M EUR

EBITDA Margin

-15%

Profit Margin

-20%

PS Ratio

0.8

PB Ratio

6.2

Company Profile

Country (HQ)

Germany

Sector

Healthcare

Industry

Biotechnology

CEO

Marc Lloret-Grau open_in_new

Employees

Founded

2005

Website

bio-gate.de open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
3.9%	7.3%	9.1%	-13%	-19%	-19%	-21%	-69%	-81%

News

Markets

Exchange	Ticker	Price	Quotes
Deutsche Börse Xetra (XETRA) MIC: XETR PRIMARY	BIG1 Bio-Gate AG Akt. nach Kapitalherabsetzung ISIN: DE000BGAG981 Shares Out.: Shares Outstanding: 10.194M¹ Shares Float: 1.172M² TV: TradingView: XETR: BIG1 SA: Stock Analysis: ETR: BIG1 YF: Yahoo Finance: BIG1.DE GF: Google Finance: FRA: BIG1 BA: Barron's: BIG1 MS: Morningstar: XETR: BIG1	0.6600 EUR	TV: TradingView: XETR: BIG1 SA: Stock Analysis: ETR: BIG1 YF: Yahoo Finance: BIG1.DE GF: Google Finance: FRA: BIG1 BA: Barron's: BIG1 MS: Morningstar: XETR: BIG1
Frankfurt Stock Exchange (FRA) MIC: XFRA	BIG1 Bio-Gate AG Akt. nach Kapitalherabsetzung ISIN: DE000BGAG981 TV: TradingView: FWB: BIG1 SA: Stock Analysis: FRA: BIG1 YF: Yahoo Finance: BIG1.F GF: Google Finance: FRA: BIG1 BA: Barron's: BIG1 MS: Morningstar: XFRA: BIG1	0.6600 EUR	TV: TradingView: FWB: BIG1 SA: Stock Analysis: FRA: BIG1 YF: Yahoo Finance: BIG1.F GF: Google Finance: FRA: BIG1 BA: Barron's: BIG1 MS: Morningstar: XFRA: BIG1

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Bio-Gate AG

Bio-Gate AG provides technologies and customized solutions for health and hygiene in Germany. The company offers HyProtect, a plasma coating which protects the surfaces of medical implants against bacterial colonization; and MicroSilver BG, an elemental microporous silver additive. It distributes its products to veterinarians and veterinary clinics. The company was incorporated in 2005 and is based in Nuremberg, Germany.

Similar Companies

Industry: Biotechnology (Germany)

Name	Market Cap (USD) diff.	PE	Country
BioNTech SE NASDAQ: BNTX	$25.69B 387K%	-	Germany
Biotest Aktiengesellschaft XETRA: BIO	$1.69B 1.46B EUR 25K%	-	Germany
CureVac N.V. NASDAQ: CVAC	$1.04B 16K%	5.0	Germany
InflaRx N.V. NASDAQ: IFRX	$143.14M 2K%	-	Germany
Darwin AG XETRA: 7V0	$107.32M 92.4M EUR 2K%	5.0	Germany
FamiCord AG XETRA: V3V	$89.49M 77.05M EUR 1K%	-	Germany

Industry: Biotechnology (Global)

Name	Market Cap (USD) diff.	PE	Country
Amgen Inc. NASDAQ: AMGN	$182.42B 3M%	23.9	United States
Gilead Sciences, Inc. NASDAQ: GILD	$159.92B 2M%	19.0	United States
argenx SE EBR: ARGX	$48.08B 41.39B EUR 725K%	39.9	Netherlands
Samsung Biologics Co.,Ltd. KRX: 207940	$44.48B 68.19T KRW 671K%	35.5	South Korea
CSL Ltd. ASX: CSL	$43.01B 60.27B AUD 649K%	29.3	Australia
Lonza Group AG SIX: LONN	$42.72B 33.71B CHF 644K%	37.2	Switzerland

chevron_leftBack